Abstract Renal osteodystrophy (ROD) is the bone pathology that occurs as an uncommon complication related to the several alterations in mineral metabolism present in patients with chronic kidney disease (CKD). This paper describes two cases of severe ROD affecting the maxilla and mandible and causing facial disfigurement of a young and a middle-aged female patient with CKD. Both patients had a history of secondary hyperparathyroidism, previously treated by surgery. The pathogenesis of the disease, as well as its clinical, imaging, and histopathological features, and management of the patient are discussed.
Introduction
Chronic kidney disease (CKD) is the progressive and irreversible loss of renal function, usually leading to end-stage renal disease, a potentially fatal condition, requiring chronic hemodialysis or kidney transplantation for survival [1, 2] . One of the complications that can arise in patients with CKD is the clinical syndrome chronic kidney disease-mineral and bone disorder (CKD-MBD), which involves changes in laboratory tests such as serum calcium, organic phosphate, parathyroid hormone (PTH), and concentrations of vitamin D derivatives; changes in bone turnover; and extraskeletal calcifications [3, 4] . Renal osteodystrophy (ROD) has recently been redefined to refer to the bone pathology from this syndrome [5] .
Advancements in the knowledge about CKD and its complications, such as secondary hyperparathyroidism (HPT-II) and ROD, resulted in a decreased frequency of significant macroscopic bone alterations in kidney patients. Nonetheless, radiographic changes of the facial skeleton still eventually occur, occasionally involving the jaws, and may represent an early sign of ROD [6] [7] [8] . This manuscript reports the details of two unusually severe maxillofacial manifestations of ROD in patients with CKD, emphasizing the laboratorial, clinical, imaging, and histological features as well as patient management.
Case reports Patient 1
A 23-year-old female was referred to the Oral and Maxillofacial Surgery Service of our department with a 4-year history of an asymptomatic, expansive mass in the right side of the face causing airway compromise and facial disfigurement (Fig. 1a) . On intraoral examination, there were macroscopic enlargement of the right maxilla and a less severe increase in volume of the right mandible (Fig. 1b) . In addition, the patient presented gingivitis, carious teeth, and malocclusion. She had a history of idiopathic CKD in advanced stage and had been receiving hemodialysis three times a week for 10 years, while on a kidney transplant waiting list. During this period, she developed HPT-II reaching 1452 pg/mL as a maximum level of PTH. The treatment was a total parathyroidectomy combined with partial autotransplantation in the forearm. Subsequently, she reported that the facial lesion size stabilized. Her current medication included folic acid, B vitamins, prednisone, Renagel, and calcium carbonate. The panoramic radiography demonstrated a prominent ill-defined radiopaque area in the maxilla affecting the maxillary sinus and a mixed radiolucency-radiopacity in the mandible. Both areas displayed a ground-glass appearance (Fig. 2a) . The clinical diagnosis of a brown tumor was suggested. Incisional biopsy of the maxillary affected area was performed under local anesthesia, and microscopic examination showed interconnected and irregularly shaped trabeculae of woven bone interspersed with loose connective tissue with sparse fibroblasts and moderate vascularization (Fig. 2b) . The histopathological diagnosis was suggestive of renal osteodystrophy. A computed tomography (CT) scan and blood tests were requested in order to plan the surgical removal of the lesion. The CT scan revealed marked osseous expansion on the right side of the face, with endophytic and exophytic growth, affecting the body of the zygomatic bone and the entire portion of the right maxilla (Fig. 3a) . The involvement of the infraorbital floor and invasion of the nasal cavity were observed, which resulted in nasal and ophthalmic functional commitment, respectively. A lateral radiograph of the thoracic spine showed an intact bone structure (Fig. 3b) 4 .72 mg/dL (normal range 2.5-4.8 mg/dL), alkaline phosphatase level of 89 international units (IU)/L (normal range 27-100 IU/L), and serum PTH of 149 pg/mL (normal 10-65 pg/mL). The patient was submitted to surgical removal of the lesion at the hospital under general anesthesia with orotracheal intubation. One day prior to the procedure, the patient underwent hemodialysis, and due to the CKD status and thrombocytopenia, a hemodynamic preparation was conducted preoperatively and in the immediate postoperative period. Hence, the infiltration of 2 bags of platelet-rich plasma and 10 units of cryoprecipitate was used as suggested by the hematology service of the hospital. During surgery, a WeberFerguson incision was made, followed by dissection in planes (maintaining the integrity of the oral mucosa and attached gingiva) to obtain a proper visualization of the lesion (Fig. 4a) . Due to the extension of the lesion far to the medial, reaching the nasal cavity, orbital floor, hemi-maxilla, and zygomatic bone, only the osteoplasty and plasty of the surrounding soft tissue were performed, avoiding the mutilation of the patient and restoring the normal conformation of the face. The lesion invading the region of the nasal cavity was removed, in order to improve the breathing. After the procedure, the patient went to the intensive care unit and underwent hemodialysis 1 day after surgery. The fragments sent for pathological analysis revealed the same characteristics of the specimen previously obtained from incisional biopsy. The final pathologic diagnosis was consistent with ROD. One year after the surgery (Fig. 4b) , the patient showed no evidence of any increase of volume in the maxilla and is preparing for the removal of the mandibular lesion, as well as for the kidney transplant.
Patient 2
A 44-year-old woman presented an extraoral appearance of significant swelling in the middle and lower third of the face (Fig. 5a) ; thus, the clinical description of "leontiasis ossea" was presented. On intraoral examination, a hard and asymptomatic swelling in the right maxilla was evident, as well as in the mentonian area of the mandible, both covered by normal mucosa (Fig. 5b) . The maxillary lesion was expanding the buccal bone plate along with the hard palate. In the mandible, significant expansion in the buccal bone plate mandible involving the region between teeth 36 and 46 was observed, changing the normal teeth arrangement. The patient complained of difficulty breathing through the nose at night. The patient first noted the enlargement 6 years earlier which steadily increasing since then. Medical history showed hypertension and a 10-year history of CKD for which she has been Fig. 4 Once the lesion was exposed during surgery, it revealed bleeding aspect (a). Postoperative appearance 1 year after surgery (b) receiving hemodialysis three times a week. During this period, the patient developed HPT-II, achieving a maximum value of serum parathyroid hormone (PTH) of 1056 pg/mL (normal 10-65 pg/mL). The patient underwent total parathyroidectomy associated with partial autotransplantation in the forearm 1 year before being referred to our department. Her medication included losartan potassium and clonidine hydrochloride. Panoramic radiography showed a marked expansion of the maxilla and mandible, with a ground-glass appearance and teeth hypercementosis (Fig. 6 ). There were no bone manifestations at other areas of the body. Laboratory examination showed current red blood cell count of 4. (Fig. 7) . The clinical, biochemical, imaging, and microscopic studies lead to a diagnosis of osteitis fibrosa consistent with ROD. The patient was submitted to osteoplasty of both lesions by an intraoral approach in the hospital under general anesthesia. Sections of the collected specimen confirmed the histopathological diagnosis osteitis fibrosa consistent with ROD. Ten months after the surgery, the patient shows no noticeable bone changes on her facial contour and is under nephrologic care (Fig. 8 ).
Discussion
Patients with CKD commonly have alterations in several mineral metabolisms including hyperphosphatemia, hypocalcemia, and 1,25-dihydroxyvitamin D 3 or calcitrol (active metabolite of vitamin D), which eventually lead to a compensatory overproduction of PTH by parathyroid glands in a condition known as HPT-II [9] [10] [11] . As renal function declines, 1,25-dihydroxyvitamin D 3 synthesis becomes impaired, which leads to deficiency in renal calcium absorption, resulting in hypocalcemia. The calcium sensing receptor (CaSR), which is highly expressed in the parathyroid glands, senses the low serum calcium concentrations, leading to a compensatory increase in PTH (HPT-II) in the attempt to maintain the homeostasis of calcium [10] . In the meantime, the reduction of glomerular filtration also leads to impaired phosphate excretion, elevating the serum concentration of phosphate. Hyperphosphatemia can act by directly stimulating PTH synthesis and parathyroid hyperplasia and indirectly promoting HPT-II by decreasing the serum calcium level [1, 2, 10] . Excess of PTH acts in the transformation of the inactive form of vitamin D to 1,25-dihydroxyvitamin D 3 in the kidney and influences the development and activity of osteoclasts, osteoblasts, and osteocytes, thereby affecting bone turnover [1, 4] .
Due to the mineral alterations, patients with ROD should run basic blood tests, including electrolytes, full blood cell count, PTH, and alkaline phosphatase levels [2] . The laboratory findings of both patients revealed a serum PTH level slightly elevated, but when it is compared to the levels before the removal of the parathyroid glands, the considerable improvement in the HPT-II status became evidently unmistakable. Especially in patient 1, this fact was supported by the demonstrated normal levels of calcium, phosphorus, and alkaline phosphatase, the latter being a biochemical marker and, together with the PTH, commonly used in the diagnosis of different forms of bone disease associated with CKD [12] .
Usually, the alterations in bone metabolism are diagnosed by laboratory tests before the development of macroscopic skeletal changes [7, 10] . The majority of macroscopic manifestations of ROD present as diffuse jaw enlargement [13] . However, recently, the pattern of localized expansion was reported to be more common than originally recognized [5] . Patient 1 exhibited localized enlargements of the maxilla and mandible, causing facial disfigurement, while the bone alterations of patient 2 looked more diffuse. In addition, the alterations were exclusively in the jaw bones, any manifestation in long bones and aorta being discarded.
The extreme clinical manifestation of ROD is denominated leontiasis ossea represented by hyperostotic changes in the facial bones and may cause an expansion of the malar processes, a reduced nasomaxillary angle, widening of the nares, flattening of the nasal bridge, and an increase of interdental space [9] . This ultimate condition results in lion-like facial features observed in patient 2, which clinically and histologically resembles the big head disease observed in animals with hyperparathyroidism secondary to kidney problems or to diets rich in phosphorus and calcium deficiency [2] .
Such facial disfigurement as in leontiasis ossea is an uncommon feature of ROD and is not specific because it can be present in other lesions such as fibrous dysplasia, or Paget's disease of bone [9] . Craniofacial fibrous dysplasia is asymmetric and can cause cranial neuropathies, headaches, and occlusal discrepancies [2] . In contrast to ROD, fibrous dysplasia typically occurs in childhood and accompanies a biochemical profile within normal limits [5, 13] . Concerning Paget's disease, the rates of osteoclastic and osteoblastic activities are elevated, resulting in skeletal remodeling and weakened deformed bones. However, when it affects jawbones, it is typically bilateral [14] . Moreover, even showing increased levels of alkaline phosphatase, the serum level of calcium in Paget's disease is normal [2] .
Some radiographic findings of ROD of the jaws also occur in fibrous dysplasia, or Paget's disease of bone, such as ground-glass appearance, observed in both current patients; hypercementosis noticed on patient 2; and bone resorption with loss of lamina dura [13] . Some of the radiographic alterations of ROD include demineralization of bone, delayed tooth eruption, mixed osteolysis and sclerosis (salt-and-pepper) trabecular appearance, absence of lamina dura, thickening of the diploic space of the calvarium, dental spacing and mobility, jaw fracture, and poor definition of anatomical landmarks [9] . The CT scan can show changes in the trabecular pattern and bone expansion and, along with magnetic resonance imaging, is helpful for diagnosis and treatment planning [15] .
Microscopic and pathologic features of ROD are dynamic in their progression and can be subdivided into low-and highturnover bone diseases or with a combined pattern of the two categories [16] . Osteitis fibrosa represents increased bone turnover as it is associated with hyperparathyroidism, while decreased turnover mainly characterizes osteomalacia and adynamic (aplastic) bone disease [7, 13] . Osteitis fibrosa used to be the most common type of ROD; however, in the last decades, adynamic bone disease has become the most common form [17] . Microscopic findings of osteitis fibrosa reveal prominent peritrabecular fibrosis associated with an increased number and activity of osteoclasts associated with increased numbers of osteoblasts and osteoid [2, 13, 18] . Those features were present in patient 2, justifying the diagnosis of osteitis fibrosa. On the other hand, osteomalacia is characterized by defective mineralization and increased osteoid production mainly caused by the decrease of 1,25-dihydroxyvitamin D 3 concentrations, usually causing osseous pain and musculoskeletal disability and making the patient at risk of osteopenia, bone deformity, and fracture [1, 4, 5] . Adynamic bone disease
